Fresenius SE Total Current Liabilities 2016-2024 | FSNUY

Fresenius SE total current liabilities from 2016 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Fresenius SE total current liabilities for the quarter ending June 30, 2024 were $9.957B, a 43.13% decline year-over-year.
  • Fresenius SE total current liabilities for 2023 were $10.098B, a 29.83% decline from 2022.
  • Fresenius SE total current liabilities for 2022 were $14.39B, a 19.25% decline from 2021.
  • Fresenius SE total current liabilities for 2021 were $17.82B, a 18.04% increase from 2020.
Fresenius SE Annual Total Current Liabilities
(Millions of US $)
2023 $10,098
2022 $14,390
2021 $17,820
2020 $15,097
2019 $15,550
2018 $15,678
2017 $12,055
2016 $9,455
2015 $8,227
Fresenius SE Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $9,957
2024-03-31 $9,094
2023-12-31 $10,098
2023-09-30 $31,769
2023-06-30 $17,509
2023-03-31 $17,087
2022-12-31 $14,390
2022-09-30 $14,969
2022-06-30 $15,218
2022-03-31 $388
2021-12-31 $17,820
2021-09-30 $18,103
2021-06-30 $18,319
2021-03-31 $19,226
2020-12-31 $15,097
2020-09-30 $16,197
2020-06-30 $17,004
2020-03-31 $17,640
2019-12-31 $15,550
2019-09-30 $15,323
2019-06-30 $15,449
2019-03-31 $15,529
2018-12-31 $15,678
2018-09-30 $15,459
2018-06-30 $14,458
2018-03-31 $13,826
2017-12-31 $12,055
2017-09-30 $12,513
2017-06-30 $11,405
2017-03-31 $10,853
2016-12-31 $9,455
2016-09-30 $9,351
2016-06-30 $9,101
2016-03-31 $8,163
2015-12-31 $8,227
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00